Carcinogenesis of Environmentally Relevant Ni Compounds
环境相关镍化合物的致癌作用
基本信息
- 批准号:6648316
- 负责人:
- 金额:$ 53.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-02-01 至 2006-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In the past several years we have demonstrated that carcinogenic nickel compounds inactivate g ne expression by enhancing DNA methylation and inhibiting histone acetylation. The long-term goals of this grant proposal are to study the epigenetic mechanisms of nickel carcinogenesis. The short-term goals of the proposal are to study the mechanism by which nickel silences genes through DNA methylation and a newly discovered mechanism involving inhibition of histone H4 acetylation. We believe that these mechanisms involve nickel-binding to histidine at position 18 on the N-terminal tail of histone H4. In the absence of histone acetylation, an acidic region of H2A and H2B interact avidly with the basic 1ysines of the histone H4 tail. The specific aims of the grant proposal are to study the mechanism by which nickel inhibits the acetylation of lysines of H3 and H4 tails with the hypothesis that nickel-binding to histidine 18 on the N-terminal of H4 is responsible for a selective inhibition of H4 acetylation since H3 lacks a metal binding amino acid on its tail. We will study nickel-binding to H4 using the whole protein and model peptides with various analytical tools, such as XAS, in collaboration with inorganic chemists, Drs. Maria Zoroddu and Michael Maroney. We will also invest ate the relationship between histone acetylation and gene silencing in mammalian cells using histone deacetylase inhibitors, such as trichostatin A. We will examine whether trichostatin A can antagonize nickel-induced silencing and can revert nickel-silenced genes both in the G12/G10 mammalian system, as well as the URA3 gene which is silenced by nickel in yeast. We will utilize the chromosome immunoprecipitaton assay to investigate whether nickel effects gene-specific histone H3 or H4 acetylation. This assay involves crosslinking of histories to DNA with formaldehyde after which the DNA is fragmented to 0.5-2 Kb fragments, immunoprecipitated with antibodies against acetylated H3 and H4 and the crosslinked proteins are released and specific DNA sequences associated with acetylated histones are assessed by quantitative PCR. This assay will be applied tooth the G12 nickel-silenced system, as well as the URA3 gene in the nickel- silenced yeast system. Using the Affymetrix GeneChip, we will identify human genes turned-off following exposure to nickel compounds and reactivated by the histone deacetylase inhibitor trichostatin A. These human genes will then be further examined by the chromosome immunoprecipitaton assay and also will be studied in terms of the effects of DNA methylation on their expression. These studies should greatly enhance our body of knowledge concerning the epigenetic mechanisms of nickel carcinogenesis.
在过去的几年中,我们已经证明了致癌镍化合物通过增强DNA甲基化并抑制组蛋白乙酰化来使G NE表达失活。该赠款提案的长期目标是研究镍癌发生的表观遗传机制。该提案的短期目标是研究通过DNA甲基化沉默基因和一种涉及抑制组蛋白H4乙酰化的新发现的机制。我们认为,这些机制涉及组蛋白H4的N末端尾部的镍结合到组氨酸。在没有组蛋白乙酰化的情况下,H2A和H2B的酸性区域与组蛋白H4尾的碱性1肌胺狂热相互作用。赠款提案的具体目的是研究镍抑制H3和H4尾巴赖氨酸的乙酰化的机制,假设H4的N末端对组氨酸18的镍结合构成了H4乙酰化的选择性抑制,因为H3缺乏H3缺乏金属结合在其尾部上的金属结合氨基酸。我们将使用整个蛋白质和模型肽使用各种分析工具(例如XAS)与无机化学家DRS一起研究H4的镍结合。 Maria Zoroddu和Michael Maroney。 We will also invest ate the relationship between histone acetylation and gene silencing in mammalian cells using histone deacetylase inhibitors, such as trichostatin A. We will examine whether trichostatin A can antagonize nickel-induced silencing and can revert nickel-silenced genes both in the G12/G10 mammalian system, as well as the URA3 gene which is silenced by nickel in yeast.我们将利用染色体免疫蛋白酶测定法研究镍效应基因特异性组蛋白H3还是H4乙酰化。该测定法涉及与甲醛与DNA进行交联,然后将DNA碎片碎片至0.5-2 kb片段,用抗乙酰化H3和H4的抗体对免疫沉淀,并通过定量PCR释放与乙酰化组织酮相关的交联蛋白,并释放与乙酰化组织酮相关的特定DNA序列。该测定法将被牙齿添加到G12镍脱脂系统以及镍静音酵母系统中的URA3基因。使用Affymetrix Genechip,我们将在暴露于镍化合物后识别人类基因,并由组蛋白脱乙酰基酶抑制剂Trichostatin A重新激活。然后,这些人类基因将通过染色体免疫原子化测定进一步研究,并将以DNA甲基化对其表达的影响进行研究。这些研究应大大增强我们关于镍癌发生的表观遗传机制的知识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Max Costa其他文献
Max Costa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Max Costa', 18)}}的其他基金
Persistent transcriptional changes induced by nickel through epigenetic alterations
镍通过表观遗传改变诱导持续转录变化
- 批准号:
10077549 - 财政年份:2020
- 资助金额:
$ 53.7万 - 项目类别:
Persistent transcriptional changes induced by nickel through epigenetic alterations
镍通过表观遗传改变诱导持续转录变化
- 批准号:
9899647 - 财政年份:2020
- 资助金额:
$ 53.7万 - 项目类别:
Persistent transcriptional changes induced by nickel through epigenetic alterations
镍通过表观遗传改变诱导持续转录变化
- 批准号:
10515635 - 财政年份:2020
- 资助金额:
$ 53.7万 - 项目类别:
Persistent transcriptional changes induced by nickel through epigenetic alterations
镍通过表观遗传改变诱导持续转录变化
- 批准号:
10294236 - 财政年份:2020
- 资助金额:
$ 53.7万 - 项目类别:
Arsenic and Nickel Carcinogenesis in Human Lung Cells
砷和镍对人肺细胞的致癌作用
- 批准号:
10470848 - 财政年份:2019
- 资助金额:
$ 53.7万 - 项目类别:
Arsenic carcinogenesis and disruption of histone variant H3.3 assembly
砷致癌和组蛋白变体 H3.3 组装的破坏
- 批准号:
10407027 - 财政年份:2019
- 资助金额:
$ 53.7万 - 项目类别:
MEG3 deletion drives lung tumorigenesis due to environmental nickel exposure
由于环境镍暴露,MEG3 缺失导致肺部肿瘤发生
- 批准号:
9852426 - 财政年份:2019
- 资助金额:
$ 53.7万 - 项目类别:
Arsenic and Nickel Carcinogenesis in Human Lung Cells
砷和镍对人肺细胞的致癌作用
- 批准号:
10004646 - 财政年份:2019
- 资助金额:
$ 53.7万 - 项目类别:
Arsenic carcinogenesis and disruption of histone variant H3.3 assembly
砷致癌和组蛋白变体 H3.3 组装的破坏
- 批准号:
10631227 - 财政年份:2019
- 资助金额:
$ 53.7万 - 项目类别:
Arsenic and Nickel Carcinogenesis in Human Lung Cells
砷和镍对人肺细胞的致癌作用
- 批准号:
10681242 - 财政年份:2019
- 资助金额:
$ 53.7万 - 项目类别:
相似国自然基金
仙茅酚苷类成分靶向组蛋白去乙酰化酶HDAC1抑制BMSC衰老防治老年性骨质疏松的机制
- 批准号:82304806
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
丁酸上调HSD11b2乙酰化抑制HPA轴激活改善孤独症样社交障碍机制研究
- 批准号:82372559
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
高糖水平通过JUN乙酰化修饰上调NCAPD3促进结直肠癌发生的分子机制
- 批准号:82303250
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
芪苓温肾消囊颗粒通过HDAC5调控GATA1启动子区H3K27乙酰化改善PCOS妊娠早期流产的机制研究
- 批准号:82374498
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Cancer prevention by indole-3-carbinol via modulation of the epigenome
通过调节表观基因组通过吲哚-3-甲醇预防癌症
- 批准号:
7661019 - 财政年份:2009
- 资助金额:
$ 53.7万 - 项目类别:
Cancer prevention by indole-3-carbinol via modulation of the epigenome
通过调节表观基因组通过吲哚-3-甲醇预防癌症
- 批准号:
7783782 - 财政年份:2009
- 资助金额:
$ 53.7万 - 项目类别:
Carcinogenesis of Environmentally Relevant Ni Compounds
环境相关镍化合物的致癌作用
- 批准号:
6917123 - 财政年份:1991
- 资助金额:
$ 53.7万 - 项目类别:
Carcinogenesis of Environmentally Relevant Ni Compounds
环境相关镍化合物的致癌作用
- 批准号:
6771136 - 财政年份:1991
- 资助金额:
$ 53.7万 - 项目类别: